Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral misoprostol versus intravenous oxytocin for labor induction
IRCT20171111037374N1Phase 3Completed
- Sponsor
- Fasa University of Medical Sciences
- Start
- Dec 2017
- Modality
- Recombinant Proteins and Enzymes, Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of misoprostol and oxytocin in Pregnancy prolongation and induced labor (2 arms), sponsored by Fasa University of Medical Sciences. Primary endpoints: Successful delivery within 48 hours after intervention, Route of delivery and 4 more. Started Dec 2017; status: completed.
02
Drugs
misoprostoloxytocin
03
Conditions
Pregnancy prolongationinduced labor
Beyond the preview
Go deeper on IRCT20171111037374N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20171111037374N1.